Gene Liau - Net Worth and Insider Trading
Gene Liau Net Worth
The estimated net worth of Gene Liau is at least $296,352 dollars as of 2024-11-10. Gene Liau is the EVP Research & Preclinical Dev of Stoke Therapeutics Inc and owns about 21,351 shares of Stoke Therapeutics Inc (STOK) stock worth over $296,352. Details can be seen in Gene Liau's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gene Liau has not made any transactions after 2021-03-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gene Liau
Gene Liau Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gene Liau owns 1 companies in total, including Stoke Therapeutics Inc (STOK) .
Click here to see the complete history of Gene Liau’s form 4 insider trades.
Insider Ownership Summary of Gene Liau
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STOK | Stoke Therapeutics Inc | 2021-03-02 | EVP Research & Preclinical Dev |
Gene Liau Latest Holdings Summary
Gene Liau currently owns a total of 1 stock. Gene Liau owns 21,351 shares of Stoke Therapeutics Inc (STOK) as of March 2, 2021, with a value of $296,352.
Latest Holdings of Gene Liau
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STOK | Stoke Therapeutics Inc | 2021-03-02 | 21,351 | 13.88 | 296,352 |
Holding Weightings of Gene Liau
Gene Liau Form 4 Trading Tracker
According to the SEC Form 4 filings, Gene Liau has made a total of 5 transactions in Stoke Therapeutics Inc (STOK) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Stoke Therapeutics Inc is the sale of 5,344 shares on March 2, 2021, which brought Gene Liau around $336,298.
Insider Trading History of Gene Liau
- 1
Gene Liau Trading Performance
Gene Liau Ownership Network
Ownership Network List of Gene Liau
Ownership Network Relation of Gene Liau
Gene Liau Owned Company Details
What does Stoke Therapeutics Inc do?
Who are the key executives at Stoke Therapeutics Inc?
Gene Liau is the EVP Research & Preclinical Dev of Stoke Therapeutics Inc. Other key executives at Stoke Therapeutics Inc include Chief Medical Officer Barry Ticho , 10 percent owner Skorpios Trust , and COO & CBO Huw M. Nash .
Stoke Therapeutics Inc (STOK) Insider Trades Summary
Over the past 18 months, Gene Liau made no insider transaction in Stoke Therapeutics Inc (STOK). Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 134,116 shares made by Barry Ticho , a net sale of 18,022 shares made by Jonathan Allan , and a net sale of 56,616 shares made by Huw M. Nash .
In summary, during the past 3 months, insiders sold 1,967,500 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 1,967,500 shares. During the past 18 months, 5,803,870 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,803,870 shares.
Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Stoke Therapeutics Inc Insider Transactions
Gene Liau Mailing Address
Above is the net worth, insider trading, and ownership report for Gene Liau. You might contact Gene Liau via mailing address: C/o Stoke Therapeutics, Inc., 45 Wiggins Ave, Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
